There are novel approaches based on consensus algorithms and data fusion techniques that have demonstrated a dramatic improvement when different kinds of in vitro, in vivo, and clinical data were used to decode complex pharmacokinetics and pharmacodynamics issues . In other words, the ADMETox properties predictions must be addressed by a multidisciplinary group of specialists that consider chemical, biological, and clinical implications related to these.